Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo

被引:134
作者
Coleman, JE
Huentelman, MJ
Kasparov, S
Metcalfe, BL
Paton, JFR
Katovich, MJ
Semple-Rowland, SL
Raizada, MK
机构
[1] Univ Florida, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA
[2] Univ Florida, McKnight Brain Inst, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA
[3] Univ Florida, Coll Med, Gainesville, FL 32610 USA
[4] Univ Florida, Coll Pharm, Dept Pharmacodynam, Gainesville, FL 32610 USA
[5] Univ Bristol, Sch Med Sci, Dept Physiol, Bristol BS8 1TD, Avon, England
关键词
cardiomyocytes; in vivo gene delivery; neurons; retina; transfection;
D O I
10.1152/physiolgenomics.00135.2002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The aim of this study was to develop an efficient method for packaging and concentrating lentiviral vectors that consistently yields high-titer virus on a scale suitable for in vivo applications. Transient cotransfection of 293T packaging cells with DNA plasmids encoding lentiviral vector components was optimized using SuperFect, an activated dendrimer-based transfection reagent. The use of SuperFect allowed reproducible and efficient production of high-titer lentiviral vector at concentrations greater than 1 x 10(7) transducing units per ml (TU/ml) and required less than one-third of the total amount of DNA used in traditional calcium phosphate transfection methods. Viral titers were further increased using a novel concentration protocol that yielded an average final titer of 1.4 x 10(10) TU/ml. Lentiviruses produced using these methods exhibited efficient transduction of central nervous system and peripheral tissues in vivo. The method is reproducible and can be scaled up to facilitate the use of these vectors in animal studies.
引用
收藏
页码:221 / 228
页数:8
相关论文
共 24 条
[1]   Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males [J].
Arruda, VR ;
Fields, PA ;
Milner, R ;
Wainwright, L ;
De Miguel, MP ;
Donovan, PJ ;
Herzog, RW ;
Nichols, TC ;
Biegel, JA ;
Razavi, M ;
Dake, M ;
Huff, D ;
Flake, AW ;
Couto, L ;
Kay, MA ;
High, KA .
MOLECULAR THERAPY, 2001, 4 (06) :586-592
[2]   Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system [J].
Chang, LJ ;
Urlacher, V ;
Iwakuma, T ;
Cui, Y ;
Zucali, J .
GENE THERAPY, 1999, 6 (05) :715-728
[3]   Production and design of more effective avian replication-incompetent retroviral vectors [J].
Chen, CMA ;
Smith, DM ;
Peters, MA ;
Samson, MES ;
Zitz, J ;
Tabin, CJ ;
Cepko, CL .
DEVELOPMENTAL BIOLOGY, 1999, 214 (02) :370-384
[4]  
Coleman JE, 2002, INVEST OPHTH VIS SCI, V43, P1335
[5]   Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function [J].
Cui, Y ;
Iwakuma, T ;
Chang, LJ .
JOURNAL OF VIROLOGY, 1999, 73 (07) :6171-6176
[6]   A new-generation stable inducible packaging cell line for lentiviral vectors [J].
Farson, D ;
Witt, R ;
McGuinness, R ;
Dull, T ;
Kelly, M ;
Song, JP ;
Radeke, R ;
Bukovsky, A ;
Consiglio, A ;
Naldini, L .
HUMAN GENE THERAPY, 2001, 12 (08) :981-997
[7]   REPLICATION-COMPETENT RETROVIRAL VECTORS ENCODING ALKALINE-PHOSPHATASE REVEAL SPATIAL RESTRICTION OF VIRAL GENE-EXPRESSION TRANSDUCTION IN THE CHICK-EMBRYO [J].
FEKETE, DM ;
CEPKO, CL .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (04) :2604-2613
[8]   Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences [J].
Follenzi, A ;
Ailles, LE ;
Bakovic, S ;
Geuna, M ;
Naldini, L .
NATURE GENETICS, 2000, 25 (02) :217-+
[9]  
Huentelman MJ, 2002, METHOD ENZYMOL, V346, P562
[10]   Self-inactivating lentiviral vectors with U3 and U5 modifications [J].
Iwakuma, T ;
Cui, Y ;
Chang, LJ .
VIROLOGY, 1999, 261 (01) :120-132